Results 201 to 210 of about 2,230,930 (359)

Discovering the complete enhancer map of human herpesviruses using a natural language processing model. [PDF]

Nat Commun
Roy Chowdhury N, Ghosal D, Gurevich V, Shamay M.   +3 more
europepmc   +1 more source

Enhancing VADS – enhancing metadata

, 2009
This case study was presented at the ARLIS/UK & Ireland Cataloguing & Classification and Visual Resources Committees' study day 'Picture This! the art of cataloguing images in the digital age', Paul Mellon Centre for Studies in British Art, London, 9th September 2009.
openaire   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Enhancer-mediated NR2F2 recruitment activates BGN to promote tumor growth and shape tumor microenvironment in papillary thyroid cancer. [PDF]

Theranostics
Tao M, Ruan X, Yu J, Dong Q, Luo W, Zhang W, Tian M, Hou X, Hu L, Zhao J, Li D, Hao J, Wei S, Zheng X, Gao M.   +14 more
europepmc   +1 more source

Observation of large enhancements of charge exchange cross sections with neutron-rich carbon isotopes [PDF]

, 2016
I. Tanihata, S. Terashima, R. Kanungo, F. Ameil, J. Atkinson, Y. Ayyad, D. Cortina‐Gil, I. Dillmann, A. Estradé, A. Evdokimov, F. Farinon, H. Geißel, G. Guastalla, R. Janik, R. Knoebel, J. Kurcewicz, Yu. A. Litvinov, M. Marta, M. Mostazo, I. Mukha, C. Nociforo, H. J. Ong, S. Piétri, A. Prochazka, C. Scheidenberger, B. Sitár, P. Strmeň, M. Takechi, Junki Tanaka, H. Toki, J. E. Ramirez Vargas, J. S. Winfield, H. Weick   +32 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Evolution of repressive sequences within an enhancer contributed to morphological diversity in crucifer plants. [PDF]

Proc Natl Acad Sci U S A
Popoli A, Mentink RA, Brombach L, Papadima-Karanikou N, Buendia-Monreal M, Fang M, Joshi M, Yoshida S, Laurent S, Huijser P, Tsiantis M.   +10 more
europepmc   +1 more source

Salmon nasal cartilage proteoglycan enhances growth of normal human dermal fibroblast through Erk1/2 phosphorylation [PDF]

, 2017
Masahiro Sano, Yi Shang, Akio Nakane, Tomoaki Saito   +3 more
openalex   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Quantitative modulation of a spatial enhancer through the biophysical properties of a transcription factor binding site. [PDF]

Sci Adv
Fallon C, Ling L, Cooper BH, Ceolin S, Chiu TP, Mitra R, Mühling B, Srinivasan V, Durmaz AD, Veselinovic D, Kothari M, Fylaktakis AP, Glassford WJ, Kribelbauer-Swietek JF, Papadopoulos DK, Mann RS, Rohs R, Gompel N.   +17 more
europepmc   +1 more source